STOCK TITAN

Director at PACS Group (PACS) receives 3,497 restricted stock units grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PACS Group, Inc. reported that director Patrick Hugh Conway acquired 3,497 restricted stock units (RSUs) of Common Stock as a grant. Each RSU represents the right to receive one share of Common Stock upon vesting. According to the terms, 100% of the RSUs will vest on the earlier of March 4, 2027 or the next annual meeting following the grant date, subject to his continued service to the company.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Conway Patrick Hugh

(Last) (First) (Middle)
C/O PACS GROUP, INC.
90 S. 400 W. SUITE 700

(Street)
SALT LAKE CITY UT 84101

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/04/2026 A 3,497(1) A $0 3,497 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will vest on the earlier to occur of (i) March 4, 2027 and (ii) the date of the next annual meeting following the grant date, subject to the Reporting Person's continued service to the Issuer.
Remarks:
/s/ John Mitchell, Attorney-in-Fact 03/05/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did PACS (PACS) report for Patrick Hugh Conway?

PACS Group, Inc. reported that director Patrick Hugh Conway received a grant of 3,497 restricted stock units. Each unit represents the right to receive one share of Common Stock if and when the award vests under its stated conditions.

How many PACS Group (PACS) RSUs were granted to director Patrick Hugh Conway?

Director Patrick Hugh Conway was granted 3,497 restricted stock units of PACS Group, Inc. Common Stock. These RSUs convert into an equal number of shares upon vesting, aligning his potential ownership directly with the company’s equity.

When do Patrick Hugh Conway’s PACS (PACS) RSUs vest?

All 3,497 RSUs will vest on the earlier of March 4, 2027 or the date of the next annual meeting after the grant. Vesting is conditioned on Patrick Hugh Conway’s continued service to PACS Group, Inc. through that vesting date.

What does the Form 4 for PACS (PACS) say about the nature of Conway’s award?

The Form 4 describes Conway’s transaction as an acquisition of restricted stock units, classified as a grant, award, or other acquisition. The RSUs are non-derivative securities that settle into Common Stock upon meeting the vesting requirements.

What are restricted stock units (RSUs) in the PACS (PACS) director grant?

In this filing, RSUs give the director the right to receive one share of PACS Group, Inc. Common Stock for each unit at vesting. They do not deliver shares immediately, but only if the service-based vesting condition is satisfied.

Does the PACS (PACS) Form 4 indicate any sale of shares by Patrick Hugh Conway?

The Form 4 reflects only an acquisition of 3,497 restricted stock units by Patrick Hugh Conway. It shows no reported sales or dispositions in this transaction, focusing solely on the equity award grant to the director.
PACS Group

NYSE:PACS

PACS Rankings

PACS Latest News

PACS Latest SEC Filings

PACS Stock Data

5.59B
44.05M
Medical Care Facilities
Services-skilled Nursing Care Facilities
Link
United States
SALT LAKE CITY